Scientific Fraud: Impact of Fujii’s Data on Our Current Knowledge and Practice for the Management of Postoperative Nausea and Vomiting
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Between 1999 and 2001, Kranke et al.1–3 published 3 articles highlighting concerns with data from the numerous studies published by Dr. Yoshitaka Fujii on postoperative nausea and vomiting (PONV) management. Approximately 10 years later, Toho University Faculty of Medicine started to investigate the credibility of 9 publications by Dr. Fujii and announced in March 2012 that 8 of those studies lacked appropriate ethics committee approval. The Japanese Society of Anesthesiologists (JSA) subsequently set up a special investigation committee to assess the allegations of scientific fraud. The committee investigated 212 articles and concluded that 172 studies were fabricated and 3 were not. For 37 articles, the JSA stated that the evidence was inconclusive as to whether or not the studies were fabricated. Based on fabrication of at least 172 studies, this likely represents the largest fraud in the history of anesthesia literature. The purpose of this editorial is to provide an overview of the scope of Dr. Fujii’s publications relating to PONV, and the extent to which our knowledge and management of PONV have been affected by removing these data from the literature. Of the 249 articles published by Fujii, 122 dealt with PONV. Of these, 110 articles were randomized controlled trials (RCTs), and the remaining 12 articles were reviews. Of the 110 PONV RCTs, all but 1 were determined to be fabricated by the JSA investigation. The sole study not found to be fabricated was among those with no evidence to prove whether it was fabricated. There are several common themes in Dr. Fujii’s publications. Many of his studies were repeated in different patient populations using the same drugs or combination of drugs, and reporting very similar results. Using a meta-analytic approach, Carlisle4 demonstrated that there was almost no heterogeneity among the majority of outcomes in the studies published by Fujii (I2 = 0). The I2 test assesses the degree of heterogeneity among included studies. It can be interpreted as the percentage of the total variability in a set of effect sizes due to true heterogeneity, that is, between-studies variability. When testing similar drugs in different patient populations, some degree of heterogeneity is expected. For instance, among RCTs comparing granisetron versus metoclopramide, the I2 was 0% in Fujii’s studies for all the end points tested (nausea, vomiting, nausea or vomiting, and need for rescue antiemetics) compared with I2 ranging from 5% to 51% for studies by all other authors.4 The main focus of Dr. Fujii’s fabricated publications has been granisetron, which was allegedly investigated in 70 of his published RCTs. This included single-dose studies, dose-finding studies, and comparisons with other antiemetics mainly ramosetron, droperidol, and metoclopramide, as well as comparisons of the combination of granisetron with dexamethasone or droperidol versus single agents. In Dr. Fujii’s articles, granisetron was reported to be more effective than all those other antiemetics with the exception of ramosetron, which was more effective than granisetron from 24 to 48 hours after surgery, but had similar effectiveness from 0 to 24 hours.5 In his dose-ranging studies, the minimum effective dose for PONV prophylaxis was 40 μg/kg in adults6 and children7 when given IV, 2 mg in adults8 and 40 μg/kg in children9 when given orally, and 20 μg/kg for the treatment of PONV in adults.10 In 2001, Kranke et al.3 performed a meta-analysis on granisetron for PONV prophylaxis and found that Fujii’s results differed from those reported by other centers. Specifically, pooled results from Fujii’s studies suggested that low-dose granisetron (≤20 μg/kg) was ineffective for PONV prophylaxis and only high doses (>20 μg/kg) were effective. This was in contrast to pooled results from other centers where there was no difference in effectiveness between low-dose and high-dose granisetron. Furthermore, pooled results from the Fujii studies suggested much higher effectiveness of high-dose granisetron compared with other centers. More recent studies by other investigators have confirmed that granisetron doses as low as 0.1 mg/kg are effective for PONV prophylaxis in adults.11 In his meta-analysis comparing the results of the studies by Fujii with other authors, Carlisle4 reported that granisetron was 1.3 to 1.5 times more effective in RCTs by Fujii than by other authors. Similar to other literature, Fujii reported that the combination of granisetron with other antiemetics was more effective than each antiemetic alone. However, his publications suggested that granisetron was unique in terms of acting synergistically with other antiemetics, a finding that was not supported by the work of other authors.4 Another focus of Dr. Fujii’s publications was ramosetron, the subject of 15 published RCTs. Fujii reported that ramosetron was effective for PONV prophylaxis for 48 hours after surgery, with a minimum effective dose of 0.3 mg in adu
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the case of Fujii’s extensive publications, the effect of his misconduct on the management of postoperative nausea and vomiting appears to have only been minimised by the large volume of publications from other authors.79”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [79]
In the citing paper
“Such active dissemination by self-citation in cases of prolific misconduct also occurred in the Reuben and Fujii cases.74 79”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [79]
Citations
Cites
14 retracted
Handa, F., & Fujii, Y. (2001) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.2001.00615.x · Cited by 46
RetractedFujii, Y., & Tanaka, H. Y. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80025-x · Cited by 28
RetractedFujii, Y., Toyooka, H., & Tanaka, H. Y. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/80.6.764 · Cited by 28
RetractedFujii, Y., & Tanaka, H. Y. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85150-5 · Cited by 26
RetractedNumazaki, M., & Fujii, Y. (2003) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(03)00086-2 · Cited by 24
RetractedFujii, Y., & Nakayama, M. (2007) · The Breast Journal · doi:10.1111/j.1524-4741.2007.00497.x · Cited by 22
RetractedFujii, H. T. Y. (2001) · The European Journal of Surgery · doi:10.1080/110241501750099339 · Cited by 18
RetractedGranisetron reduces post-operative vomiting in children: a dose-ranging study
Fujii, Y., & Tanaka, H. Y. (1999) · European Journal of Anaesthesiology · doi:10.1046/j.1365-2346.1999.00423.x · Cited by 16
RetractedLow‐dose propofol to prevent nausea and vomiting after laparoscopic surgery
Fujii, Y., & Itakura, M. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.03.008 · Cited by 14
RetractedFujii, Y., & Nakayama, M. (2007) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2007.07.017 · Cited by 14
Retracted
Research works printed but not linked: 2
- Fujii, 2008, Supplemental oxygen prevents postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery., Anesth Resus, 44, 47
- Rusch, 2011, Postoperative nausea and vomiting (PONV)recommendations for risk assessment, prophylaxis and therapyresults of an expert panel meeting., Anasthesiol Intensivmed Notfallmed Schmerzther, 46, 158
Cited by
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Gan, T. J., Diemunsch, P., Habib, A. S., Kovac, A., Kranke, P., Meyer, T. A., Watcha, M., Chung, F., Angus, S., Apfel, C. C., et al. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000002 · Cited by 1,487
Self-citationFourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Gan, T. J., Belani, K. G., Bergese, S., Chung, F., Diemunsch, P., Habib, A. S., Jin, Z., Kovac, A. L., Meyer, T. A., Urman, R. D., et al. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004833 · Cited by 1,295
Self-citationAvenell, A., Stewart, F., Grey, A., Gamble, G., & Bolland, M. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031909 · Cited by 59
Assessing the Integrity of Clinical Trials Included in Evidence Syntheses
Núñez‐Núñez, M., Ibáñez, N. C., Zamora, J., Bueno‐Cavanillas, A., & Khan, K. S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20126138 · Cited by 26
von Peltz, C. A., Baber, C., & Nou, S. L. (2021) · Anaesthesia and Intensive Care · doi:10.1177/0310057x211030518 · Cited by 7
Metadata
- Authors
- Habib, A. S., & Gan, T. J.
- Affiliations
- Duke Medical Center (US)
- Duke University (US)
- Corresponding author
- Gan, Tong J.
- Venue
- Anesthesia & Analgesia
- Published
- 2013-03
- Volume
- 116
- Issue
- 3
- Pages
- 520-522
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2078359696
- Cited by
- 10
- References
- 38
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2015: 2 · 2014: 1 · 2013: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesia & Analgesia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Education › Academic integrity and plagiarism
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Physical Sciences › Mathematics › Statistics and Probability › Benford’s Law and Fraud Detection
- Keywords
- postoperative nausea and vomiting, research misconduct, data fabrication, research ethics approval, meta-analysis heterogeneity, I2 statistic, granisetron, metoclopramide, antiemetic prophylaxis, publication ethics
- MeSH terms
- Clinical Competence, Humans, Statistics as Topic, Scientific Misconduct, Practice Guidelines as Topic, Disease Management, Postoperative Nausea and Vomiting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Scientific Fraud: Impact of Fujii’s Data on Our Current Knowledge and Practice for the Management of Postoperative Nausea and Vomiting. https://app.cochat.ai/papers/10.1213/ane.0b013e31827ab7d8
- The paper
- Habib, A. S., & Gan, T. J. (2013). Scientific Fraud: Impact of Fujii’s Data on Our Current Knowledge and Practice for the Management of Postoperative Nausea and Vomiting. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0b013e31827ab7d8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.